Neuropsychiatric Disorders in Hospitalized Patients Undergoing Chimeric Antigen Receptor T-Cell Therapy for Multiple Myeloma

被引:0
作者
Lawal, Odunayo [1 ]
Lupak, Oleksandra [2 ]
Udo, Itoro [3 ]
Emole, Josephine [4 ]
机构
[1] Univ Arizona, Clin & Translat Sci Program, Tucson, AZ USA
[2] Med Univ South Carolina, Hematol Oncol, Charleston, SC 29425 USA
[3] Western Univ, Dept Psychiat, London, ON, Canada
[4] Henry Ford Hosp, Stem Cell Transplantat & Cellular Therapy, Detroit, MI 48202 USA
关键词
CT; CAR-T therapy; neuropsychiatric disorders; multiple myeloma;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
CT-423
引用
收藏
页码:S454 / S454
页数:1
相关论文
共 50 条
[41]   Recent Advances in the Use of Chimeric Antigen Receptor-Expressing T-Cell Therapies for Treatment of Multiple Myeloma [J].
Martin, Thomas ;
Jackson, Carolyn C. ;
Pacaud, Lida ;
Madduri, Deepu ;
Jagannath, Sundar .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 (01) :22-27
[42]   Chimeric Antigen Receptor T Cells in the Treatment of Multiple Myeloma [J].
Hasanali, Zainul S. ;
Razzo, Beatrice ;
Susanibar-Adaniya, Sandra P. ;
Garfall, Alfred L. ;
Stadtmauer, Edward A. ;
Cohen, Adam D. .
HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA, 2024, 38 (02) :383-406
[43]   An Assessment of the Effectiveness and Safety of Chimeric Antigen Receptor T-Cell Therapy in Multiple Myeloma Patients with Relapsed or Refractory Disease: A Systematic Review and Meta-Analysis [J].
Pereira, Rita ;
Bergantim, Rui .
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2024, 25 (09)
[44]   CD19-Targeted Chimeric Antigen Receptor T-cell Therapy for Concomitant Diffuse Large B-cell Lymphoma and Multiple Myeloma [J].
D'Ovidio, Tyler ;
Ciccolini, Kathryn ;
Kalac, Matko ;
Osman, Keren ;
Steinberg, Amir .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2023, 15 (09)
[45]   Serum soluble BCMA can be used to monitor relapse of multiple myeloma patients after chimeric antigen receptor T-cell immunotherapy [J].
Shen, Ying ;
Liu, Jie ;
Wang, Baiyan ;
Zhang, Yilin ;
Xu, Yan ;
Wang, Xiaman ;
Jia, Yachun ;
Meng, Xin ;
Wang, Xugeng ;
Fan, Xiaohu ;
He, Aili ;
Zhao, Wanhong .
CURRENT RESEARCH IN TRANSLATIONAL MEDICINE, 2023, 71 (02)
[46]   Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma [J].
Ma, Tiantian ;
Shi, Jing ;
Liu, Huasheng .
ANNALS OF HEMATOLOGY, 2019, 98 (04) :813-822
[47]   Chimeric antigen receptor T cell targeting B cell maturation antigen immunotherapy is promising for multiple myeloma [J].
Tiantian Ma ;
Jing Shi ;
Huasheng Liu .
Annals of Hematology, 2019, 98 :813-822
[48]   Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory multiple myeloma [J].
Ma, Sha ;
Li, Hujun ;
Zhou, Dian ;
Zhang, Xiaotian ;
Shi, Ming ;
Cao, Jiang ;
Qi, Yuekun ;
Xia, Jieyun ;
Liu, Yang ;
Wang, Xue ;
Li, Depeng ;
Sang, Wei ;
Yan, Zhiling ;
Zhu, Feng ;
Sun, Haiying ;
Cheng, Hai ;
Zheng, Junnian ;
Xu, Kailin ;
Li, Zhenyu ;
Qi, Kunmin ;
Wang, Ying .
CYTOTHERAPY, 2023, 25 (06) :653-658
[49]   A successful haploidentical transplantation without conditioning regimen for a relapsed/refractory multiple myeloma patient after chimeric antigen receptor T-cell therapy [J].
Dai, Zigang ;
Yu, Nanzhou ;
Cao, Yang ;
Zhou, Jianfeng ;
Zhang, Yicheng ;
Wang, Na ;
Zhou, Xiaoxi .
CYTOTHERAPY, 2025, 27 (03) :295-299
[50]   Healthcare Resource Utilization and Costs Among Patients With Relapsed/Refractory Multiple Myeloma Treated With Chimeric Antigen Receptor-T (CAR-T) Cell Therapy [J].
Jagannath, Sundar ;
Kharat, Akshay ;
Fu, Alex ;
Huo, Stephen ;
Kohli, Monal ;
Adams, Shayna ;
Umeh, Emeka ;
Foster, Miran .
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 :S511-S512